Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2023-02-23 | 2023-03-02 | 185471 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2017-05-10 | 2017-11-20 | 9951 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2024-06-27 | 2024-08-09 | 231490 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2024-10-24 | 2024-11-22 | 241078 |
| APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2024-11-29 | 2024-12-13 | 244206 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2024-12-05 | 2025-01-24 | 244910 |
| APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-10 | 131142 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-18 | 2021-02-09 | 131815 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2021-03-05 | 2021-03-15 | 135153 |
| APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-03-05 | 2021-03-15 | 135156 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2018-04-10 | 2018-08-02 | 45334 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2018-08-21 | 2018-11-15 | 58583 |
| APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2018-08-21 | 2018-11-02 | 58586 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2021-07-05 | 2022-01-31 | 141840 |
| APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2021-08-03 | 2021-09-27 | 143397 |
| APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2017-09-26 | 2018-02-26 | 23546 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2018-01-22 | 2018-04-02 | 36809 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2022-02-11 | 2022-02-22 | 154753 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2022-12-09 | 2023-02-16 | 177678 |
| APO-CEPHALEX | 500MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185480 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VORICONAZOLE | 200MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60858 |
| APO-VORICONAZOLE | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60861 |
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
| APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-09-08 | 2018-09-15 | 60867 |
| BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
| COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| DOXEPIN | 100MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65447 |
| DOXEPIN | 10MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65452 |
| DOXEPIN | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2018-10-24 | 65458 |
| DOXEPIN | 75MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65466 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
| IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
| IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
| IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-07-12 | 2019-07-13 | 89135 |
| IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
| IMIPRAMINE | 50MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4593 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |